Treatment of chemotherapy-induced neutropenia with Lipegfilgrastim (Lonquex®): First interim analysis of the non-interventional study NADIR. 6. Juni 2014 Kurbacher, C., Diel, I., Egert, M., Fietz, T., Hurtz, H., Lück, A., Weide, R., Wolff, T., Zaiss, M., Teichmann, B., Harde, J., Scheuerlein, R., 2014. Oncol Res Treat 37(suppl 5)(P512). doi:10.1159/000368945 Abstract 1st-line treatment with BR and FCR in patients with chronic lymphocytic leukamia. Knauf, W., Abenhardt, W., Engel, E., Grugel, R., Harde, J., Jänicke, M., Marschner, N., 2014. Oncol Res Treat 37 (suppl5)(P186), 50. doi:10.1159/000368945… Weiterlesen No impact of first-line systemic therapy on quality of life of patients with metastatic breast cancer? Data from the MaLife-project. Marschner, N., Tesch, H., Karcher, A., Ammon, A., Nusch, A., Boller, E., Spring, L., Jänicke, M., 2014. Oncol Res Treat 37 (suppl 5)(V371), 111. doi:10.1159/000368945… Weiterlesen